Cardiology & Internal Medicine
Chemical Computing Group
Vice President, Chief Development Officer: Rod MacKenzie is responsible for the development and advancement of Pfizer’s pipeline of medicines in several therapeutic areas, including metabolic disease and cardiovascular risks, inflammation and immunology, neuroscience, oncology and rare disease. He serves on the Portfolio Strategy and Investment Committee, which focuses on maximizing the return on R&D investment across the Pfizer portfolio.
cardiovascular, gastroenterology, sexual health, urology, and allergy and respiratory diseases